Cargando…
Beam Output Audit results within the EORTC Radiation Oncology Group network
Beam Output Auditing (BOA) is one key process of the EORTC radiation therapy quality assurance program. Here the results obtained between 2005 and 2014 are presented and compared to previous results. For all BOA reports the following parameters were scored: centre, country, date of audit, beam energ...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159966/ https://www.ncbi.nlm.nih.gov/pubmed/27978843 http://dx.doi.org/10.1186/s13014-016-0733-4 |
_version_ | 1782481851839938560 |
---|---|
author | Hurkmans, Coen W. Christiaens, Melissa Collette, Sandra Weber, Damien Charles |
author_facet | Hurkmans, Coen W. Christiaens, Melissa Collette, Sandra Weber, Damien Charles |
author_sort | Hurkmans, Coen W. |
collection | PubMed |
description | Beam Output Auditing (BOA) is one key process of the EORTC radiation therapy quality assurance program. Here the results obtained between 2005 and 2014 are presented and compared to previous results. For all BOA reports the following parameters were scored: centre, country, date of audit, beam energies and treatment machines audited, auditing organisation, percentage of agreement between stated and measured dose. Four-hundred and sixty-one BOA reports were analyzed containing the results of 1790 photon and 1366 electron beams, delivered by 755 different treatment machines. The majority of beams (91.1%) were within the optimal limit of ≤ 3%. Only 13 beams (0.4%; n = 9 electrons; n = 4 photons), were out of the range of acceptance of ≤ 5%. Previous reviews reported a much higher percentage of 2.5% or more of the BOAs with >5% deviation. The majority of EORTC centres present beam output variations within the 3% tolerance cutoff value and only 0.4% of audited beams presented with variations of more than 5%. This is an important improvement compared to previous BOA results. |
format | Online Article Text |
id | pubmed-5159966 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-51599662016-12-23 Beam Output Audit results within the EORTC Radiation Oncology Group network Hurkmans, Coen W. Christiaens, Melissa Collette, Sandra Weber, Damien Charles Radiat Oncol Short Report Beam Output Auditing (BOA) is one key process of the EORTC radiation therapy quality assurance program. Here the results obtained between 2005 and 2014 are presented and compared to previous results. For all BOA reports the following parameters were scored: centre, country, date of audit, beam energies and treatment machines audited, auditing organisation, percentage of agreement between stated and measured dose. Four-hundred and sixty-one BOA reports were analyzed containing the results of 1790 photon and 1366 electron beams, delivered by 755 different treatment machines. The majority of beams (91.1%) were within the optimal limit of ≤ 3%. Only 13 beams (0.4%; n = 9 electrons; n = 4 photons), were out of the range of acceptance of ≤ 5%. Previous reviews reported a much higher percentage of 2.5% or more of the BOAs with >5% deviation. The majority of EORTC centres present beam output variations within the 3% tolerance cutoff value and only 0.4% of audited beams presented with variations of more than 5%. This is an important improvement compared to previous BOA results. BioMed Central 2016-12-15 /pmc/articles/PMC5159966/ /pubmed/27978843 http://dx.doi.org/10.1186/s13014-016-0733-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Short Report Hurkmans, Coen W. Christiaens, Melissa Collette, Sandra Weber, Damien Charles Beam Output Audit results within the EORTC Radiation Oncology Group network |
title | Beam Output Audit results within the EORTC Radiation Oncology Group network |
title_full | Beam Output Audit results within the EORTC Radiation Oncology Group network |
title_fullStr | Beam Output Audit results within the EORTC Radiation Oncology Group network |
title_full_unstemmed | Beam Output Audit results within the EORTC Radiation Oncology Group network |
title_short | Beam Output Audit results within the EORTC Radiation Oncology Group network |
title_sort | beam output audit results within the eortc radiation oncology group network |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159966/ https://www.ncbi.nlm.nih.gov/pubmed/27978843 http://dx.doi.org/10.1186/s13014-016-0733-4 |
work_keys_str_mv | AT hurkmanscoenw beamoutputauditresultswithintheeortcradiationoncologygroupnetwork AT christiaensmelissa beamoutputauditresultswithintheeortcradiationoncologygroupnetwork AT collettesandra beamoutputauditresultswithintheeortcradiationoncologygroupnetwork AT weberdamiencharles beamoutputauditresultswithintheeortcradiationoncologygroupnetwork |